[FATE] YoY Annual Result on 31-Dec-2019 [#FY]

Stock
[FATE] Fate Therapeutics, Inc.
Announcement Date
02-Mar-2020
Financial Year
2019
Quarter
31-Dec-2019 [#FY]
Profit Trend
YoY- -46.71%
Quarter Report
FATE's Result
FATE's Financial Summary
View:
Show?
Annual Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 96,300 55,846 31,434 10,680 4,740 4,106 4,402 67.19%
PBT -281,721 -212,151 -173,387 -98,149 -66,598 -42,952 -33,462 42.60%
Tax -26,665 -5,850 -3,087 -441 2,190 297 -743 81.56%
NP -255,056 -206,301 -170,300 -97,708 -66,598 -42,952 -33,462 40.26%
Tax Rate - - - - - - - -
Total Cost 351,356 262,147 201,734 108,388 71,338 47,058 37,864 44.93%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -264.86 -369.41 -541.77 -914.87 -1,405.02 -1,046.08 -760.15 -16.10%
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -2.63 -2.18 -2.07 -1.43 -1.19 -1.02 -1.05 16.52%
EPS Diluted -2.63 -2.18 -2.07 -1.43 -1.19 -1.02 -1.05 16.52%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.